<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:bovine-ojs-tamu.tdl.org:article/9066</identifier>
				<datestamp>2025-03-26T17:16:02Z</datestamp>
				<setSpec>aabp:BS</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Thoughts and recommendations on metaphylaxis in commercial feedyard settings with an emphasis on drug selection and postmetaphylaxis intervals</dc:title>
	<dc:creator xml:lang="en">Szasz, Josh</dc:creator>
	<dc:subject xml:lang="en">feedyard</dc:subject>
	<dc:subject xml:lang="en">feedlot</dc:subject>
	<dc:subject xml:lang="en">metaphylaxis</dc:subject>
	<dc:subject xml:lang="en">antimicrobial</dc:subject>
	<dc:subject xml:lang="en">post-metaphylaxis interval,</dc:subject>
	<dc:subject xml:lang="en">post-treatment interval</dc:subject>
	<dc:description xml:lang="en">Various antimicrobial drugs are approved for metaphylaxis in cattle at high risk for developing BRD. Although many can be used successfully, some antimicrobials appear to have superior comparative effectiveness across a broad range of BRD risk lev足els. Practitioners should familiarize themselves with the avail足able literature to understand which antimicrobial(s) best meet the needs of their clients and the cattle they manage. Once a practitioner has selected an antimicrobial for metaphylaxis purposes, it is also recommended they familiarize themselves with the literature pertaining to post-metaphylaxis intervals (PMI). In general, extending PMI beyond what is tradition足ally regarded as prudent, results in reduced BRD treatments without deleterious effects on BRD mortality or growth perfor足mance. Additional considerations in selecting metaphylaxis agents and PMIs are discussed herein.</dc:description>
	<dc:publisher xml:lang="en">American Association of Bovine Practitioners</dc:publisher>
	<dc:date>2025-03-26</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://bovine-ojs-tamu.tdl.org/aabp/article/view/9066</dc:identifier>
	<dc:identifier>10.21423/aabppro20249066</dc:identifier>
	<dc:source xml:lang="en">American Association of Bovine Practitioners  Conference Proceedings; Vol. 58 No. 58 (2024): 2024 AABP Annual Conference Proceedings; 1-5</dc:source>
	<dc:source>1079-9737</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://bovine-ojs-tamu.tdl.org/aabp/article/view/9066/8738</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2025 American Association of Bovine Practitioners</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
